AGRX - Agile Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 561.24M
Enterprise Value 350.4M
Trailing P/E N/A
Forward P/E 1-3.26
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.47
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.13

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.28%
Return on Equity (ttm)-63.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.12M
Net Income Avi to Common (ttm)-17.61M
Diluted EPS (ttm)-0.5020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.56M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)285k
Total Debt/Equity (mrq)1.15
Current Ratio (mrq)8.91
Book Value Per Share (mrq)0.57

Cash Flow Statement

Operating Cash Flow (ttm)-16.14M
Levered Free Cash Flow (ttm)-9.34M

Trading Information

Stock Price History

Beta (3Y Monthly) -1.36
52-Week Change 3104.35%
S&P500 52-Week Change 34.63%
52 Week High 31.7000
52 Week Low 30.2310
50-Day Moving Average 31.4621
200-Day Moving Average 31.0854

Share Statistics

Avg Vol (3 month) 3436.63k
Avg Vol (10 day) 3140.37k
Shares Outstanding 543.74M
Float 25.48M
% Held by Insiders 11.27%
% Held by Institutions 154.21%
Shares Short (Apr 30, 2019) 4766.87k
Short Ratio (Apr 30, 2019) 43.76
Short % of Float (Apr 30, 2019) 42.63%
Short % of Shares Outstanding (Apr 30, 2019) 41.76%
Shares Short (prior month Mar 29, 2019) 4808.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A